Veeresh Kumar N. Shivamurthy
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Veeresh Kumar N. Shivamurthy has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
Abdel K. Tahari
Division of Nuclear Medicine, Russell H. Morgan Department of Radiology and Radiological Sciences, Johns Hopkins Medical Institutions, JHOC 3235, 601 N Caroline St, Baltimore, MD 21287
1 shared publicationAbdul Alchaki
1 shared publicationAda Baisre
1 shared publicationCharles Marcus
Division of Nuclear Medicine, Russell H. Morgan Department of Radiology and Radiological Sciences, Johns Hopkins Medical Institutions, JHOC 3235, 601 N Caroline St, Baltimore, MD 21287
1 shared publication- Elissa G. Yozawitz
Isabelle Rapin Division of Child Neurology of the Saul R. Korey Department of Neurology and Department of Pediatrics Albert Einstein College of Medicine and Montefiore Einstein Bronx New York USA
1 shared publication Jonathan Gursky
The Saul R. Korey Department of Neurology Albert Einstein College of Medicine Bronx New York USA
1 shared publication
Latest Publications
- 28 October 2024
- Published by Wiley in Epileptic Disorders
- Vol. 27 (1) , 100-102
A case of temporal lobe cavernoma causing epileptic spasms that resolved with surgical resection
- 28 October 2024
- Published by Wiley in Epileptic Disorders
- Vol. 27 (1) , 100-102
A case of temporal lobe cavernoma causing epileptic spasms that resolved with surgical resection
- Open Access
- 1 January 2020
- Published by Gavin Publishers
Intraventricular Neurocysticercosis Presenting as Rapidly Progressive Dementia
We present a 38-year-old Guatemalan patient who presented to our hospital with new onset dementia and confusion of 2 months duration. A diagnosis of neurocysticercosis was made based on neuroimaging, patient’s demographic information, and ELISA results. While dementia has been reported in 12.5% of cases with neurocysticercosis, rapidly progressive dementia as the sole presenting symptom is rare. Our patient was treated with Dexamethasone, Albendazole, and External Ventricular Drain (EVD) followed by Ventriculoperitoneal (VP) shunt to reduce his Intracranial Pressure (ICP). Eventually, resection of the cyst was performed. His mental status and cognition improved dramatically, and he was discharged from our hospital on a 2-week course of Albendazole. Neurocysticercosis patients with dementia and increased ICP should receive early aggressive medical and surgical intervention, which has been to improve outcome. Dementia; External ventricular drain; Hydrocephalus; Neurocysticercosis; Parasite infection
- 1 January 2020
- Published by Gavin Publishers
Open AccessIntraventricular Neurocysticercosis Presenting as Rapidly Progressive Dementia
We present a 38-year-old Guatemalan patient who presented to our hospital with new onset dementia and confusion of 2 months duration. A diagnosis of neurocysticercosis was made based on neuroimaging, patient’s demographic information, and ELISA results. While dementia has been reported in 12.5% of cases with neurocysticercosis, rapidly progressive dementia as the sole presenting symptom is rare. Our patient was treated with Dexamethasone, Albendazole, and External Ventricular Drain (EVD) followed by Ventriculoperitoneal (VP) shunt to reduce his Intracranial Pressure (ICP). Eventually, resection of the cyst was performed. His mental status and cognition improved dramatically, and he was discharged from our hospital on a 2-week course of Albendazole. Neurocysticercosis patients with dementia and increased ICP should receive early aggressive medical and surgical intervention, which has been to improve outcome. Dementia; External ventricular drain; Hydrocephalus; Neurocysticercosis; Parasite infection
- 1 January 2015
- Published by American Roentgen Ray Society in American Journal of Roentgenology
- Vol. 204 (1) , W76-W85
Brain FDG PET and the Diagnosis of Dementia
We review the role of brain FDG PET in the diagnosis of Alzheimer disease, frontotemporal dementia, dementia with Lewy bodies, and vascular dementia. Characteristic spatial patterns of brain metabolism on FDG PET can help differentiate various subtypes of dementia. In patients with different subtypes of dementia, FDG PET/CT shows distinct spatial patterns of metabolism in the brain and can help clinicians to make a reasonably accurate and early diagnosis for appropriate management or prognosis.
- 1 January 2015
- Published by American Roentgen Ray Society in American Journal of Roentgenology
- Vol. 204 (1) , W76-W85
Brain FDG PET and the Diagnosis of Dementia
We review the role of brain FDG PET in the diagnosis of Alzheimer disease, frontotemporal dementia, dementia with Lewy bodies, and vascular dementia. Characteristic spatial patterns of brain metabolism on FDG PET can help differentiate various subtypes of dementia. In patients with different subtypes of dementia, FDG PET/CT shows distinct spatial patterns of metabolism in the brain and can help clinicians to make a reasonably accurate and early diagnosis for appropriate management or prognosis.